The Future of Cancer Care: A $326 Billion Revolution on the Horizon

Global Antibody Drug Conjugates Market Witnessing Strong Growth with a 9% CAGR by 2030 - Daily Investor Hub

The antibody drug conjugates (ADCs) market is projected to grow at a CAGR of ~9% over the forecast period. Major factors driving growth include the growing prevalence of cancer, increasing demand for targeted cancer therapies, advancement in ADC technology, growing investment in R&D for introducing new antibody-drug conjugates, and increasing approvals by regulatory bodies such as the FDA and EMA for ADCs. However, the market encounters certain …

The Future of Cancer Care: A $326 Billion Revolution on the Horizon

The Cancer Therapeutics Market is projected to grow from USD 162.58 billion in 2024 to USD 326.35 billion by 2032, driven by a robust CAGR of 9.1% from 2025 to 2032. North America, particularly the United States, leads in innovation, while global regions including Europe, Asia-Pacific, and emerging markets contribute to market expansion. Technological advancements combined with economic and non-economic factors support diverse cancer treatments,…